For over 40 years, our dedication to patients has been evident in our commitment to furthering cancer care through clinical research. With more than 10,000 patients enrolled in over 1,500 clinical trials, Illinois CancerCare’s award winning research program stands tall amongst other nationally recognized research institutions and academic centers. Illinois CancerCare offers a diverse clinical trial menu comprised of preventative, diagnostic, treatment, symptom management, survivorship, registry, and cancer care delivery trials (CCDR).
Providing community access to groundbreaking research is the driving force behind our research program. Through the Heartland Cancer Research National Cancer Institute Community Oncology Research Program (Heartland Cancer Research NCORP), the physicians are able to bring state-of-the-art cancer research to the residents of central and western Illinois. Illinois CancerCare participates in research with many large national cancer research bases, including the Alliance for Clinical Trials in Oncology (Alliance), ECOG-ACRIN Cancer Research Group, NRG Oncology, Southwest Oncology Group (SWOG), the University of Rochester Cancer Consortium (URCC), as well as other top medical research facilities, such as Mayo Clinic.
Our knowledgeable physician team attends conferences throughout the year to stay abreast of promising new agents and combination therapies coming down the pipeline. Illinois CancerCare maintains a membership in the University of Chicago’s Personalized Cancer Care Consortium (PCCC) and continues to work directly with top pharmaceutical companies, providing our patients with access to the new cutting edge agents that could become the standard therapy of tomorrow. Illinois CancerCare played an integral part in early research of drugs like oxaliplatin (Eloxatin), irinotecan (Camptosar) and epoetin alfa (Procrit), which have become essential tools in the arsenal of chemotherapy and supportive care drugs.
Illinois CancerCare has successfully investigated trials utilizing immunotherapy, chemotherapy, vaccine therapy, hormonal therapy, biomarkers, devices, non-malignant concerns, etc. To view our full menu of clinical trials currently available, click here. For more information about a specific clinical trial, contact our research team directly at 309-243-3605.